BRIEF published on 11/12/2024 at 14:55, 8 days 22 hours ago Declaration of BOIRON voting rights as of October 31, 2024 Voting Rights Actions AMF Transparency BOIRON
BRIEF published on 10/10/2024 at 10:05, 1 month 11 days ago BOIRON Declares its Shares and Voting Rights as of September 30, 2024 Voting Rights Capital Actions AMF BOIRON
BRIEF published on 09/27/2024 at 11:55, 1 month 24 days ago Provisional calendar of upcoming publications and events 2025 Turnover General Assembly BOIRON Financial Publications Quiet Period
BRIEF published on 09/19/2024 at 17:50, 2 months 1 day ago Boiron Laboratories first half 2024 sales and results Financial Results Investments Turnover BOIRON Homeopathy
BRIEF published on 09/11/2024 at 17:45, 2 months 9 days ago BOIRON: Declaration of voting rights as of August 31, 2024 Voting Rights Capital Actions AMF BOIRON
BRIEF published on 08/07/2024 at 11:25, 3 months 14 days ago Declaration of voting rights as of July 31, 2024 by the company BOIRON Voting Rights Capital Actions BOIRON July 2024
BRIEF published on 07/09/2024 at 10:10, 4 months 12 days ago Declaration of voting rights by BOIRON as of June 30, 2024 Voting Rights Capital AMF 2024 BOIRON
BRIEF published on 07/03/2024 at 18:50, 4 months 17 days ago Evolution of Governance at Laboratoires BOIRON Governance Healthcare Management BOIRON Homeopathy
PRESS RELEASE published on 07/03/2024 at 18:45, 4 months 17 days ago EVOLUTION OF GOVERNANCE Laboratoires BOIRON announces a new CEO and Board Chairman. Thierry BOIRON replaces Valérie LORENTZ-POINSOT as CEO, while Anabelle FLORY-BOIRON takes over as Chairman of the Board CEO Appointment Governance Evolution Laboratoires BOIRON Board Chairman Appointment Health Solutions
BRIEF published on 07/03/2024 at 18:35, 4 months 17 days ago Evolution of governance at BOIRON Governance Nomination Strategy BOIRON
Published on 11/21/2024 at 13:30, 24 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 24 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 54 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 54 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 54 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 19 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 39 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 34 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
